Conquering melanoma and skin cancer

Melanoma and Skin Cancer Trials (MASC Trials) specialises in investigator-initiated melanoma and skin cancer research.

We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes.

0

Trials

0

Hospital
Trial Sites

0

Countries

0

Patients
Enrolled

Donate to Melanoma Margins Trial

Help melanoma patients like Stuart have improved outcomes after surgery.

Donate to our Melanoma Margins Trial before 30 June.

2023 AOMA Virtual Summit

Saturday, 24 June 2023

Australasia’s premier cross-disciplinary ocular melanoma meeting for health professionals and consumers.

This free virtual event will include a scientific program and presentations focused on consumer involvement.

What We Do

MASC Trials brings together a powerful network of over 2,250 professionals who represent the many disciplines critical to our work – oncologists, surgeons, radiation specialists, nurses, allied health professionals, health economists, statisticians, research scientists, clinical research associates, data managers, patient advocates and others.

With expert support from our Advisories and our trials staff, MASC Trials leads and designs research and clinical trial development, and provides project management for multicentre, national and international collaborations.

Collaboration drives outcomes

Recruiting Trials

Active Trials Closed for Recruitment

Trials in Start-Up Phase

Completed Trials

Research Proposals

TWITTER

LATEST NEWS

OUR PARTNERS